Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does trastuzumab emtansine's patent expiry affect drug prices?What excipients are combined with ruxolitinib in apotex's medication?Drug patent watch trametinib?Is clarinex off patent?Does lipitor's effectiveness decrease with high fat meals?
See the DrugPatentWatch profile for Kalbitor
Kalbitor (ecallantide) is manufactured by Daiichi Sankyo.
Kalbitor is marketed in the United States by Daiichi Sankyo.
Kalbitor is used to treat acute attacks of hereditary angioedema (HAE). The manufacturer information is tied to the drug product (ecallantide), not to the indication itself.
Yes. Drug brands can be marketed by different companies depending on the country, while the active ingredient remains ecallantide. If you share your country (or whether you mean U.S. availability), I can narrow it to the correct local manufacturer/marketer.
Other Questions About Kalbitor :